Clinical trials in China are getting attention at an international oncology gathering in Chicago. China’s surging biotechnology industry is fueling alarm that U.S. dominance in the field is waning.
Previous Story
S.E.C. Proposes to Kill Climate Change Disclosure Rule
Next Story
Making Motherhood and a Long Tennis Career Possible
